ArticleAmerican journal of cancer research2025
La-related protein 1 drives malignant progression and epithelial-mesenchymal transition in anaplastic thyroid carcinoma.
Article in American journal of cancer research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Conserved Functions of LARP1 Proteins in Eukaryotes.Wiley interdisciplinary reviews. RNAReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anaplastic thyroid cancer (ATC) is an extremely aggressive and lethal malignancy characterized by a very short average survival time following diagnosis. Understanding the molecular mechanisms that drive this aggressiveness is vital for developing effective therapies. This study aimed to elucidate the role and function of La-related protein 1 (LARP1) in ATC progression. We quantitatively analyzed LARP1 expression in patient samples and ATC cell lines. Functional assays were performed to investigate LARP1's involvement in cancer-related processes, including inhibition of apoptosis, promotion of cell cycle progression, proliferation, colony formation, migration, and invasion. Our results revealed significantly elevated LARP1 expression in ATC tissues, which may be associated with poor patient prognosis. Experimental data demonstrated that LARP1 enhances oncogenic activities, promoting proliferative and invasive behaviors. These findings provide compelling evidence that LARP1 plays a crucial role in ATC malignancy, offering insights into pathophysiology and potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.